| NCOAX | RITEX | NCOAX / RITEX | |
| Total Expense Ratio | 1.02 | 0.70 | 146% |
| Annual Report Gross Expense Ratio | 1.09 | 0.70 | 156% |
| Fund Existence | 16 years | 24 years | - |
| Gain YTD | 2.316 | 1.583 | 146% |
| Front Load | 5% | N/A | - |
| Min. Initial Investment | 2500 | 250 | 1,000% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 553M | 28.5B | 2% |
| Annual Yield % from dividends | 7.25 | 6.30 | 115% |
| Returns for 1 year | 8.21 | 7.06 | 116% |
| Returns for 3 years | 31.12 | 31.20 | 100% |
| Returns for 5 years | 24.65 | 25.64 | 96% |
| Returns for 10 years | 74.43 | 80.82 | 92% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| FTXH | 36.32 | 0.49 | +1.37% |
| First Trust Nasdaq Pharmaceuticals ETF | |||
| JFR | 7.65 | 0.05 | +0.66% |
| Nuveen Floating Rate Income Fund | |||
| IBGA | 24.35 | 0.04 | +0.16% |
| iShares iBonds Dec 2044 Term Trsy ETF | |||
| EVIM | 53.24 | -0.04 | -0.07% |
| Eaton Vance Intermediate Muncpl Inc ETF | |||
| COLO | 43.54 | -0.67 | -1.52% |
| Global X MSCI Colombia ETF | |||